Why the study?
Does AI-augmented pre-procedural planning reduce the need for leaflet modification in patients undergoing valve-in-valve or redo-TAVR?
Cohort (n=157)
Does AI-augmented pre-procedural planning reduce the need for leaflet modification in patients undergoing valve-in-valve or redo-TAVR?
Odds Ratio: 2.76 (95% CI 1.03–7.4)
Absolute Event Rate: 24.1% vs 46.8%
p-value: p=0.021
AI-augmented pre-procedural planning safely reduces the need for leaflet modification in high-risk valve-in-valve and redo-TAVR patients by reclassifying risk.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Stinis et al. (2026) conducted a cohort in Valve-in-valve (ViV) or redo-TAVR at risk for coronary obstruction (n=157). AI-Augmented pre-procedural planning vs. Non-AI (traditional CTA-based planning) was evaluated on Leaflet modification among CTA high-risk patients (OR 2.76, 95% CI 1.03-7.40, p=0.021).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: